Publication | Closed Access

Efficacy and safety of the angiotensin II receptor blocker losartan for hypertrophic cardiomyopathy: the INHERIT randomised, double-blind, placebo-controlled trial

HypertensionCardiomyopathyCardiovascular DiseaseMedicineAntihypertensive TherapyCardiovascular PharmacologyPlacebo-controlled TrialHypertrophic CardiomyopathyPharmacotherapyPharmacologyCardiologyCardiovascular Genetics